Screening– tag –
-
Amerigo Scientific Unveils Advanced iPSC-Derived Cells to Propel Biomedical Research and Cell Therapy
24-7PressRelease.com (Amerigo Scientific発表) USA Overview Amerigo Scientific has launched a new portfolio of high-purity, iPSC-derived cells, including advanced reporter lines, aimed at accelerating biomedical research and cell therapy ... -
3D Bioprinted Organoids Pave the Way for Clinical Translation in Oncology, Regenerative Medicine, and Drug Discovery
Reproductive Biology (Oxford Academic) UK Overview 3D bioprinted organoids are demonstrating significant advances in oncology, regenerative medicine, and drug discovery by more faithfully replicating in vivo tissue structures and functio... -
UCLA Health Accelerates Cancer Therapy Screening with 3D Bioprinting and AI-Integrated Platform
UCLA Health Jonsson Comprehensive Cancer Center USA Overview UCLA Health Jonsson Comprehensive Cancer Center researchers have developed an innovative platform combining 3D bioprinting, advanced imaging, and AI to rapidly identify promisi... -
ChemCopilot’s Generative AI Translates Natural Language to SMILES, Automating Molecular Design
ChemCopilot Unknown Overview ChemCopilot has launched a groundbreaking generative AI model for molecular design, capable of translating natural language prompts into stable SMILES strings. This innovative system automates the entire work... -
Imperial College London’s DeCAF-Pearl AI Model Enables Practical Large-Scale Molecular Screening, Surpassing AlphaFold 3 Efficiency
Imperial College London UK Overview Researchers at Imperial College London, in collaboration with the Genesis Research Team, have developed DeCAF-Pearl, a new AI model based on flow maps that makes large-scale molecular screening practic... -
Latent Labs’ Generative AI Transforms Molecular Design, Producing Macrocyclic Peptides and Antibody Candidates in Weeks
CVPR (Computer Vision and Pattern Recognition) USA Overview Latent Labs, through its Latent-X1 and Latent-Y platforms, is transforming drug discovery by enabling de novo molecular design from intent, rather than traditional library scree... -
bioRxiv: APOSM Improves Generative Small-Molecule Design via Pairwise Preference Learning, Accelerating Lead Optimization
bioRxiv USA Overview A bioRxiv preprint introduces APOSM, an active-learning algorithm that enhances generative small-molecule design by employing pairwise preference learning for surrogate models, moving beyond absolute scores. This met... -
AI/Machine Learning Drives Target Identification and Precision Nanomedicine in Drug Discovery, Enhancing Candidate Selection and Pathway Analysis
Dove Medical Press USA Overview Machine learning (ML) and deep learning (DL) strategies are advancing drug discovery by enhancing target identification and precision nanomedicine. These technologies leverage virtual screening and bioacti... -
CombiCult® Screening Platform Establishes Feeder-Free Bioreactor Scalability for iPSC-Derived NK Cell Manufacturing
Frontiers (Preprint) Germany Overview This preprint reports research developing a feeder-free protocol for generating mature, functional iPSC-derived natural killer (iNK) cells using the high-throughput combinatorial screening platform C... -
Mount Sinai Scientists Discover Hidden Drug-Binding Pocket in Cancer Protein PKMYT1, Highlighting AI Drug Discovery’s Capabilities and Limitations
Mount Sinai - New York USA Overview Mount Sinai scientists discovered a previously overlooked drug-binding pocket in the cancer-related protein PKMYT1. This finding, while highlighting AI drug discovery's capabilities and limitations, op...
